Good morning :)
Park Medi World Ltd

Park Medi World Ltd

PARKHOSPS Share Price

NSE
259.190.00% (+0.00)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹11,195 cr, stock is ranked 525

Stock is 3.36x as volatile as Nifty

PARKHOSPS Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹11,195 cr, stock is ranked 525

Stock is 3.36x as volatile as Nifty

PARKHOSPS Performance & Key Metrics

PARKHOSPS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
44.159.94
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
42.256.290.45%

PARKHOSPS Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

PARKHOSPS Company Profile

Park Medi World Ltd operates a chain of over 13 NABH-accredited multi-specialty hospitals in North India, offering more than 30 super specialty and specialty medical services including cardiology, neurology, urology, gastroenterology, oncology, and various surgical disciplines.

Investor Presentation

View older View older 

May 12, 2026

PDF
View Older Presentations

PARKHOSPS Similar Stocks (Peers)

Compare with peers Compare with peers 

PARKHOSPS Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
61.93
61.93
1Y Return
20.25%
20.25%
Buy Reco %
89.29
89.29
PE Ratio
69.04
69.04
1Y Return
10.88%
10.88%
Buy Reco %
86.96
86.96
PE Ratio
69.60
69.60
1Y Return
32.69%
32.69%
Buy Reco %
83.33
83.33
PE Ratio
100.76
100.76
1Y Return
32.78%
32.78%
Buy Reco %
100.00
100.00
PE Ratio
46.78
46.78
1Y Return
7.71%
7.71%
Buy Reco %
83.33
83.33
Compare with Peers

PARKHOSPS Sentiment Analysis

PARKHOSPS Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

PARKHOSPS Stock Summary · February 2026

During its inaugural earnings call, the company showcased a strong commitment to accessible and affordable healthcare, emphasizing strategic expansion in high-potential regions like Uttar Pradesh, where it aims to significantly increase bed capacity. Management expressed confidence in future growth, supported by a proactive approach to operational efficiency and cost management, including a focus on advanced medical technologies and a low capital expenditure strategy. Despite challenges in staffing new facilities, the company is poised to enhance its service offerings, particularly in high-end medical procedures, while maintaining strong financial metrics, including an EBITDA margin of 27%. The recent CGHS rate hikes are expected to bolster revenue, reflecting a positive market sentiment and a strategic shift towards a more diverse payer mix, ultimately positioning the company for sustained success in the evolving healthcare landscape.

PARKHOSPS Stock Growth Drivers
PARKHOSPS Stock Growth Drivers
9
  • Commitment to Quality Healthcare

    Park Medi World Limited has established itself as a leader in the healthcare sector since

  • Operational Efficiency and Growth

    The company has achieved significant operational efficiencies, with an average occupancy rate of approximately 65%

PARKHOSPS Stock Challenges
PARKHOSPS Stock Challenges
2
  • Cautious Financial Projections

    The management has indicated that the recent CGHS rate hike, which ranges from 12% to

  • Employee Cost Management Challenges

    The company is facing challenges in managing employee costs, particularly concerning full-time doctors. Although they

end marker

PARKHOSPS Forecast

PARKHOSPS Forecasts

Price

Revenue

Earnings

PARKHOSPS

PARKHOSPS

Income

Balance Sheet

Cash Flow

PARKHOSPS Income Statement

PARKHOSPS Income Statement

Loading...

Quarterdec 2024mar 2025jun 2025sep 2025dec 2025mar 2026
Total Revenue362.89362.49405.16418.23419.07467.92
Operating & Other expensessubtract265.32265.49294.06297.46310.56333.05
Depreciation/Amortizationsubtract15.0315.5313.4314.8915.3017.51
Interest & Other Itemssubtract15.7315.6515.1314.5314.9513.98
Taxes & Other Itemssubtract21.2221.0024.0917.7927.5232.53
EPS1.191.361.522.041.351.78

PARKHOSPS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual Report Pending

Investor Presentation

May 12PDF
Jan 28PDF
Jan 28PDF
 

PARKHOSPS Stock Peers

PARKHOSPS Past Performance & Peer Comparison

PARKHOSPS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Park Medi World Ltd43.379.94
Apollo Hospitals Enterprise Ltd61.9310.830.24%
Max Healthcare Institute Ltd69.0410.620.20%
Fortis Healthcare Ltd69.607.910.10%

PARKHOSPS Stock Price Comparison

Compare PARKHOSPS with any stock or ETF
Compare PARKHOSPS with any stock or ETF
PARKHOSPS
Loading...

PARKHOSPS Holdings

PARKHOSPS Shareholdings

PARKHOSPS Promoter Holdings Trend

PARKHOSPS Promoter Holdings Trend

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

PARKHOSPS Institutional Holdings Trend

PARKHOSPS Institutional Holdings Trend

Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.40%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

PARKHOSPS Shareholding Pattern

PARKHOSPS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding82.89%5.62%3.63%0.86%6.99%

Mar 2025

Dec 2025

Mar 2026

PARKHOSPS Shareholding History

PARKHOSPS Shareholding History

MarDec '25Mar0.00%1.28%0.86%

Mutual Funds Invested in PARKHOSPS

Mutual Funds Invested in PARKHOSPS

No mutual funds holding trends are available

Top 5 Mutual Funds holding Park Medi World Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
1.8672%1.55%0.18%20/103 (+3)
0.7939%1.90%0.44%37/68 (+5)
0.5148%0.94%0.25%46/60 (+2)

Compare 3-month MF holding change on Screener

PARKHOSPS Insider Trades & Bulk Stock Deals

PARKHOSPS Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing PARKHOSPS stock

smallcases containing PARKHOSPS stock

Looks like this stock is not in any smallcase yet.

PARKHOSPS Events

PARKHOSPS Events

PARKHOSPS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

PARKHOSPS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

PARKHOSPS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

PARKHOSPS has not given any dividends in last 5 years

PARKHOSPS Dividends

PARKHOSPS Dividends

Hmm, looks like data is unavailable here. Please come back after some time

PARKHOSPS Stock News & Opinions

PARKHOSPS Stock News & Opinions

Earnings
Park Medi World consolidated net profit rises 58.03% in the March 2026 quarter

Net profit of Park Medi World rose 58.03% to Rs 70.86 crore in the quarter ended March 2026 as against Rs 44.84 crore during the previous quarter ended March 2025. Sales rose 30.09% to Rs 460.41 crore in the quarter ended March 2026 as against Rs 353.92 crore during the previous quarter ended March 2025. For the full year,net profit rose 28.01% to Rs 258.12 crore in the year ended March 2026 as against Rs 201.64 crore during the previous year ended March 2025. Sales rose 20.51% to Rs 1679.36 crore in the year ended March 2026 as against Rs 1393.57 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales460.41353.92 30 1679.361393.57 21 OPM %27.6624.99 -26.4626.62 - PBDT120.9081.36 49 417.05342.57 22 PBT103.3965.83 57 354.58285.67 24 NP70.8644.84 58 258.12201.64 28 Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Park Medi World to table results

Park Medi World will hold a meeting of the Board of Directors of the Company on 12 May 2026.

2 weeks agoCapital Market - Live
Spotlight
Park Medi World rises after launching Panchkula hospital

The newly launched facility is aimed at strengthening access to tertiary and quaternary care across the Tricity region, covering Haryana, Punjab, Himachal Pradesh, and Chandigarh. The move is expected to reduce dependence on metro cities such as Delhi for advanced treatments. The Panchkula hospital is equipped with advanced diagnostics, modular operation theatres, and critical care infrastructure. It will offer services across major specialties including oncology, neurosciences, orthopedics, cardiology, and robotic-assisted procedures, with a significant focus on high-acuity and critical care. The launch comes alongside the ongoing expansion of the company's Mohali facility, further scaling its regional presence. With this, the group's combined capacity in the Tricity region is expected to reach around 850 beds. Park Group currently operates 16 hospitals with a total capacity of 3,960 beds. The company is also in the process of adding five more hospitals and expanding existing facilities, which is expected to increase total capacity to 5,460 beds by March 2028. On a consolidated basis, net profit of Park Medi World rose 11.38% to Rs 50.78 while net sales rose 17.76% to Rs 409.97 crore in Q3 December 2025 over Q3 December 2024.

1 month agoCapital Market - Live
Corporate
Park Medi World launches multi-specialty hospital in Panchkula

Park Group of Hospitals has today launched advanced multi-super specialty hospital in Panchkula, alongside the ongoing expansion of its Mohali facility, strengthening access to advanced healthcare across the Tricity region. The hospital has been developed to address the growing demand for tertiary and quaternary care services across Haryana, Punjab, Himachal Pradesh, and Chandigarh. By bringing high-end medical care closer to patients, the hospital aims to reduce dependence on metro cities such as Delhi for advanced treatments. The Panchkula hospital is equipped with advanced diagnostics, modular operation theatres, critical care infrastructure, and will deliver comprehensive care across key specialties including oncology, neurosciences, orthopedics, cardiology, and critical care including robotic-assisted procedures. Designed with a strong focus on high-acuity care, a significant proportion of beds are dedicated to critical care services.

1 month agoCapital Market - Live
Corporate
Park Medi World to launch Panchkula Hospital on 10 April

Park Medi World set to launch Panchkula Hospital on 10 April 2026 instead of previously announced 29 March 2026. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Park Medi World board approves launch of Panchkula hospital and expansion of Mohali hospital

The board of Park Medi World at its meeting held on 10 March 2026 has approved the launch of a multispecialty hospital at Panchkula on 29 March 2026. The board also approved the addition of bed capacity y of Grecian Super Speciality Hospital, Mohali (Mohali Hospital) by adding 150 beds to the existing bed capacity of 350 beds. The Mohali Hospital is run and operated by RGS Healthcare, subsidiary of the company. Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Park Medi World consolidated net profit rises 11.38% in the December 2025 quarter

Net profit of Park Medi World rose 11.38% to Rs 50.78 crore in the quarter ended December 2025 as against Rs 45.59 crore during the previous quarter ended December 2024. Sales rose 17.76% to Rs 409.97 crore in the quarter ended December 2025 as against Rs 348.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales409.97348.13 18 OPM %24.2523.78 - PBDT93.5781.83 14 PBT78.2766.81 17 NP50.7845.59 11 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Park Medi World to table results

Park Medi World will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Board of Park Medi World approves acquisition of Krishna Super-speciality Hospital

The board of Park Medi World at its meeting held on 05 January 2026 has approved the acquisition of whole of existing shareholding of Krishna Super-speciality Hospital which owns and operates Mahip Hospitals for a consideration of Rs 40 crore. Strategically positioned in the heart of Bathinda, Krishna Super-speciality Hospital serves as a vital healthcare hub for both urban and rural districts, offering a centralized location for multiple super-specialties. Park Medi World has been managing operations of Krishna Super-speciality Hospital since July 2025, and has now acquired 100% shareholding from the current promoters. With the addition of this hospital, Park Group increases its hospital capacity and strengthens its infrastructure, supporting its plan to reach a total of 5,260 beds by March 2028.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Board of Park Medi World approved acquisition of KP Institute of Medical Sciences, Agra

The board of Park Medi World at its meeting held on 19 December 2025 has approved the acquisition of 100% stake in KP Institute of Medical Sciences (KPIMS), Agra, Uttar Pradesh, in an all-cash transaction amounting Rs 245 crore. Since its launch in 2023, KPIMS has become a prominent multi-specialty provider for Agra and neighbouring areas being one of the biggest healthcare facilities in the region. Upon consummation of the acquisition, KPIMS will be a 360 beded multi super speciality hospital. Its NABH accreditation, comprehensive super-specialty services, and inclusion in major insurance and government schemes, position KPIMS strongly for sustained market growth. Powered by Capital Market - Live

5 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Park Medi World Ltd (PARKHOSPS) today?

    The share price of PARKHOSPS as on 22nd May 2026 is ₹259.19. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Park Medi World Ltd (PARKHOSPS) share?

    The past returns of Park Medi World Ltd (PARKHOSPS) share are
    • Past 1 week: 4.92%
    • Past 1 month: 15.11%
    • Past 3 months: 40.58%
    • Past 6 months: 75.19%
    • Past 1 year: 75.19%
    • Past 3 years: N/A%
    • Past 5 years: 75.19%

  3. What are the peers or stocks similar to Park Medi World Ltd (PARKHOSPS)?
  4. What is the market cap of Park Medi World Ltd (PARKHOSPS) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Park Medi World Ltd (PARKHOSPS) is ₹11195.22 Cr as of 22nd May 2026.

  5. What is the 52 week high and low of Park Medi World Ltd (PARKHOSPS) share?

    The 52-week high of Park Medi World Ltd (PARKHOSPS) is ₹266.80 and the 52-week low is ₹138.10.

  6. What is the PE and PB ratio of Park Medi World Ltd (PARKHOSPS) stock?

    The P/E (price-to-earnings) ratio of Park Medi World Ltd (PARKHOSPS) is 43.37. The P/B (price-to-book) ratio is 9.94.

  7. Which sector does Park Medi World Ltd (PARKHOSPS) belong to?

    Park Medi World Ltd (PARKHOSPS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  8. How to buy Park Medi World Ltd (PARKHOSPS) shares?

    You can directly buy Park Medi World Ltd (PARKHOSPS) shares on Tickertape. Simply sign up, connect your demat account and place your order.